Company research / PRME
Prime Medicine, Inc. (PRME)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Prime Medicine, Inc. reported revenue of $4.63M. Revenue grew 55.3% from the prior annual period.
Key ratios (year ended 2025-12-31)
n/m
Operating margin
n/m
Net margin
-166.4%
Return on year-end equity
55.3%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.